Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
334970
vs
K
KOSPI 200
Over the past 12 months, Prestige Biologics Co Ltd has underperformed KOSPI 200, delivering a return of -60% compared to KOSPI 200's +53% growth.
Stocks Performance
334970 vs KOSPI 200
Performance Gap
334970 vs KOSPI 200
Performance By Year
334970 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Prestige Biologics Co Ltd
Glance View
Prestige Biologics is a South Korean biopharmaceutical services company that helps drug makers develop and manufacture biologic medicines. Its work is centered on contract development and manufacturing, so it does not mainly sell its own branded drugs. Instead, it provides the technical know-how, facilities, and regulated production process needed to turn a biologic drug concept into something that can be made reliably for testing or commercial use. Its customers are typically biotech and pharmaceutical companies that need outside help with complex products such as antibodies and other protein-based medicines. Prestige Biologics earns money by charging for development work, process support, and manufacturing services. In simple terms, it gets paid to act as a specialist partner that can handle parts of the drug-making chain that many smaller drug companies do not have in-house. What makes this business different is that biologic drugs are harder to make than traditional pills. They require careful control, specialized equipment, and strict quality systems. That gives contract manufacturers like Prestige Biologics an important role in the industry: they sit between drug discovery companies and the market, helping promising biologic medicines move from the lab to real production.